Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 171 institutions that hold shares in the stock, with a total of 43.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.07 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
4,543,895
shares
|
$111 Million
1.19% of portfolio
|
Q2 2025
Added 18.49%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
4,216,084
shares
|
$103 Million
2.65% of portfolio
|
Q3 2025
New holding
|
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Nov 14, 2025 Q3 2025 |
3,190,510
shares
|
$77.6 Million
0.1% of portfolio
|
Q2 2025
Added 82.4%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
2,528,446
shares
|
$61.5 Million
0.0% of portfolio
|
Q3 2025
Added 2.02%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Nov 12, 2025 Q3 2025 |
2,199,652
shares
|
$53.5 Million
0.21% of portfolio
|
Q2 2025
Added 169.9%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,193,950
shares
|
$53.4 Million
0.0% of portfolio
|
Q2 2024
Added 27.79%
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
1,577,283
shares
|
$38.4 Million
6.34% of portfolio
|
Q3 2025
Reduced 22.01%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
1,468,737
shares
|
$35.7 Million
0.01% of portfolio
|
Q3 2025
Added 147.25%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,259,749
shares
|
$30.6 Million
12.76% of portfolio
|
Q2 2025
Reduced 16.92%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,200,000
shares
|
$29.2 Million
0.02% of portfolio
|
Q4 2023
Added 13.21%
|
|
|
Sg Americas Securities, LLC
|
Oct 23, 2025 Q3 2025 |
1,157,383
shares
|
$28.2 Million
0.08% of portfolio
|
Q3 2025
Added 0.72%
|
|
|
Menora Mivtachim Holdings Ltd.
|
Nov 13, 2025 Q3 2025 |
1,152,531
shares
|
$28 Million
0.12% of portfolio
|
Q2 2025
Reduced 49.96%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
1,000,000
shares
|
$24.3 Million
0.89% of portfolio
|
Q2 2025
New holding
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
888,933
shares
|
$21.6 Million
0.01% of portfolio
|
Q3 2025
Added 3140.5%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
819,446
shares
|
$19.9 Million
0.0% of portfolio
|
Q3 2025
Added 1.46%
|
|
|
Migdal Insurance & Financial Holdings Ltd.
|
Oct 30, 2025 Q3 2025 |
770,909
shares
|
$18.8 Million
0.17% of portfolio
|
Q2 2025
Reduced 1.98%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
717,347
shares
|
$17.5 Million
1.57% of portfolio
|
Q3 2025
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
689,000
shares
|
$16.8 Million
0.46% of portfolio
|
Q3 2025
Added 44.02%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
687,475
shares
|
$16.7 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
679,000
shares
|
$16.5 Million
0.81% of portfolio
|
Q3 2025
Reduced 68.92%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
602,277
shares
|
$14.7 Million
0.0% of portfolio
|
Q3 2025
Added 10.88%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
534,545
shares
|
$13 Million
0.0% of portfolio
|
Q3 2025
Added 44.1%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
507,531
shares
|
$12.3 Million
0.0% of portfolio
|
Q3 2025
Added 510.41%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
471,229
shares
|
$11.5 Million
0.0% of portfolio
|
Q3 2025
Added 0.11%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
424,916
shares
|
$10.3 Million
0.0% of portfolio
|
Q3 2025
Added 46.23%
|
|